Tag: CBT > FDA Policy on CBD

Top Stories

FDA Takes Hands-Off Approach to Medicare’s CBD Product Program

The U.S. Food and Drug Administration commissioner clarified the agency’s enforcement posture related to CBD product coverage under Medicare’s new plan.

April 2, 2026

CBD Industry

White House Schedules Meeting for FDA’s New CBD Compliance Enforcement Policy

The president’s Office of Information and Regulatory Affairs will review the proposed rule on April 1.

March 26, 2026

Cannabis Rescheduling

Trump Promotes Hemp-Derived CBD For Senior Health Care in Shared Video

The president shared a video advocating for Medicare coverage for CBD and to fully integrate cannabis into the health care system for those 65 and older.

September 29, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Hemp Research

Amazon’s CBD, Hemp and Delta-8 Problem

A new study of hemp products sold on Amazon found that nearly half contained no hemp, several contained high doses of delta-8 THC, and more than half made an unapproved medical claim, among other concerns.

March 21, 2024

Legislation and Regulation

FDA Chooses LightLab 3 Cannabis Analyzer to Enhance Consumer Safety, Regulate the Industry

The administration’s decision stems from concerns associated with food-related products containing CBD and Delta-8 THC.

August 25, 2023

CBD Industry

Council for Federal Cannabis Regulation Proposes to Congress a Framework for FDA to Regulate CBD

The council submitted a 26-page response to a formal request for information calling for immediate regulation under existing law.

August 23, 2023

CBD Industry

Hemp Numbers Plummet Across the Board in 2022 USDA Acreage and Production Survey

The value of industrial hemp totaled $238 million in 2022, down 71% from $824 million in 2021.

April 28, 2023

CBD Industry

US Lawmakers Reintroduce Bipartisan Bills to Regulate CBD

The reintroduction of the measures comes after the FDA called on Congress to regulate CBD in dietary supplements, conventional foods and animal products.

March 17, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023

CBD Industry

How 22nd Century Group Supplies Cannabinoids for Clinical Trials

Amid the FDA’s evolving guidance, the plant biotechnology company, which has long focused on the tobacco industry, has expanded to the cannabis space to create commercially desirable cultivars.

February 7, 2023

Hemp Regulations in U.S.

Finding the Best Path Forward: FDA’s Norman Birenbaum Talks Hemp-Derived Product Regulation

The FDA’s senior public health adviser discusses the agency’s recent announcement that Congress must establish a new regulatory framework for hemp-derived products—and what comes next.

February 1, 2023